Robert Thorne

Company: Denali Therapeutics

Job title: Denali Fellow, Head of Postdoc Program

Seminars:

Panel Discussion: Extrapolating Neurological Indications with the Greatest Potential to Leverage Intranasal Administration 9:00 am

Empowering opioid overdose, bipolar disorder, anxiety, depression and more with the potential advantages of nasal formulations, such as increased specificity and enhanced potency Brainstorming innovative approaches for quantifying subjective metrics like migraine pain relief, anosmia reduction, taste enhancement, and mood improvement for robust quality control Delving into anticipated advancements, concerning challenges and expected priorities across…Read more

day: Conference Day Two

The Fate of Nasally Administered Antibodies: Olfactory & Trigeminal Pathways to the Brain & Delivery to the Lymphnodes & Circulation 11:30 am

Delving into strategies for crafting particles that are not only smaller but precisely tailored to enable API bypass of the blood-brain barrier when delivered to the upper nasal cavity Sharing best practices to assess and maintain the desired particle size for delivery to the brain Reducing additional challenges, including prolonging mucosal retention time, enhancing penetration…Read more

day: Conference Day One